1-2 of 2
Hyoung Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

APOBEC3A catalyzes mutation and drives carcinogenesis in vivo

Emily K. Law, Rena Levin-Klein, Matthew C. Jarvis, Hyoung Kim, Prokopios P. Argyris, Michael A. Carpenter, Gabriel J. Starrett, Nuri A. Temiz, Lindsay K. Larson, Cameron Durfee, Michael B. Burns, Rachel I. Vogel, Spyridon Stavrou, Alexya N. Aguilera, Sandra Wagner, David A. Largaespada, Timothy K. Starr, Susan R. Ross, Reuben S. Harris
Journal: Journal of Experimental Medicine
J Exp Med (2020) 217 (12): e20200261.
https://doi.org/10.1084/jem.20200261
Published: 01 September 2020
View article titled, APOBEC3A catalyzes mutation and drives carcinogenesis in vivo
Open the PDF for APOBEC3A catalyzes mutation and drives carcinogenesis in vivo in another window
Journal Articles

PKA-activated ApAF–ApC/EBP heterodimer is a key downstream effector of ApCREB and is necessary and sufficient for the consolidation of long-term facilitation

Jin-A Lee, Sue-Hyun Lee, Changhoon Lee, Deok-Jin Chang, Yong Lee, Hyoung Kim, Ye-Hwang Cheang, Hyoung-Gon Ko, Yong-Seok Lee, Heejung Jun, Dusan Bartsch, Eric R. Kandel, Bong-Kiun Kaang
Journal: Journal of Cell Biology
J Cell Biol (2006) 174 (6): 827–838.
https://doi.org/10.1083/jcb.200512066
Published: 11 September 2006
View article titled, PKA-activated ApAF–ApC/EBP heterodimer is a key downstream effector of ApCREB and is necessary and sufficient for the consolidation of long-term facilitation
Open the PDF for PKA-activated ApAF–ApC/EBP heterodimer is a key downstream effector of ApCREB and is necessary and sufficient for the consolidation of long-term facilitation in another window
Includes: Supplementary data